LIVE STREAMING
Dr. Stacey Trooskin appointed as Mazzoni Center's new Executive Medical Officer. Courtesy Photo.
Dr. Stacey Trooskin appointed as Mazzoni Center's new Executive Medical Officer. Courtesy Photo.

Mazzoni Center appoints new executive medical officer

MÁS EN ESTA SECCIÓN

Llegó la nieve a Pensilvania

Líos financieros en Septa

Temple nombra a Pedro Ramos

Tristeza en ASPIRA

Lebanon recauda fondos

Todo sigue igual

COMPARTA ESTE CONTENIDO:

Mazzoni Center announced earlier this week that it has appointed Dr. Stacey Trooskin as its new Executive Medical Officer.

In the role, Dr. Trooskin will lead the Center’s team of providers in key service areas, including primary medical care, HIV and STD prevention, testing, and treatment, gender affirming care, and behavioral health.

“I am thrilled to join the Mazzoni Center team,” said Dr. Trooskin in a statement. “I am looking forward to working with Mazzoni Center's extraordinary staff to support the critical work they do every day and to guide clinical growth to meet the needs of the community.”

Dr. Trooskin’s appointment as Executive Medical Officer is an extension of a less formal role she began with Mazzoni Center in March as an Executive Medical Consultant. In the former role, her focus was on providing guidance to the Center’s executive leadership team, facilitating increased clinical productivity, and developing new clinical policies and procedures. 

Dr. Trooskin comes to Mazzoni Center with two decades of experience focusing on infectious disease.

In addition to her new role, she also serves as a faculty at the University of Pennsylvania’s Perelman School of Medicine. 

Most recently, Dr. Trooskin served as Chief Medical Officer for Philadelphia FIGHT Community Health Centers. Prior to that, she served as FIGHT’s Director of Viral Hepatitis Programs.

Dr. Trooskin is an internist specializing in infectious disease, with a strong interest in public health, particularly the epidemiology of hepatitis C and identifying and overcoming barriers to testing and treatment.

Sultan Shakir, Mazzoni Center President and CEO, said in a statement, “When we look at the increasing challenges faced by the LGBTQ community, from bans on trans health care across the country to the shifting landscape of health insurance, it’s clear that Dr. Trooskin’s demonstrated leadership will help ensure that Mazzoni Center continues to evolve to meet the needs of the LGBTQ community by providing high-quality, culturally competent, and community-focused health care.”

She completed a three-year term of service as a member of the American Association for the Study of Liver Diseases and Infectious Disease Society of America’s HCV treatment guidance panel, and currently serves as the Chief Medical Advisor to the National Viral Hepatitis Roundtable and as the Medical Director for the Health Federation’s HCV technical assistance program called “C Change.”

Throughout her career, Dr. Trooskin has built a strong reputation for her activism and advocacy around issues related to access to HCV testing and treatment, particularly for incarcerated individuals and individuals who use drugs.

That same activism and advocacy, coupled with her decades of experience, is what she will bring to the table in her newest role. 

Mazzoni Center is the premier health and wellness center serving Philadelphia’s LGBTQ community and the largest LGBTQ nonprofit in the city.